A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria
Open Access
- 1 March 2020
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 156 (3) , 270-279
Abstract
Necrobiotic xanthogranuloma (NXG) is a non–Langerhans cell histiocytosis first described by Kossard and Winkelmann1 in 1980. It is typically associated with paraproteinemia attributable to plasma-cell dyscrasias or lymphoproliferative disorders.2 In addition to serving as a skin sign of systemic disease, NXG may result in cosmetic disfigurement. Extracutaneous involvement including the eye, heart, gastrointestinal tract, liver, and lung may result in organ dysfunction and death.1,3-5 Clinically, yellow-to-orange papules, plaques, and/or nodules in a periorbital distribution are classic; however, other morphological characteristics and sites have been described.6 Histopathologically, NXG demonstrates palisading granulomas with lymphoplasmacytic infiltrate and zones of necrobiosis. Cholesterol clefts and Touton or large, bizarre foreign body giant cells are other classical features.6 The pathogenesis of NXG remains unknown; however, a role for paraprotein-lipoprotein interaction has been hypothesized.7,8 Evaluation of 12 skin-biopsy specimens by Wood et al9 in 2009 found no evidence to support a monoclonal plasma-cell proliferation within the inflammatory infiltrate.Keywords
This publication has 160 references indexed in Scilit:
- Necrobiotic xanthogranulomaJournal of Cutaneous and Aesthetic Surgery, 2012
- Spectacular skin nodules: Cutaneous necrobiotic xanthogranuloma without paraproteinemiaIndian Journal of Dermatology, 2012
- Complete Response to Thalidomide and Dexamethasone in a Patient With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathy: A Case Report and Review of the LiteratureClinical Lymphoma Myeloma and Leukemia, 2011
- A 7-Year History of Necrobiotic Xanthogranuloma following Asymptomatic Multiple Myeloma: A Case ReportDermatology Research and Practice, 2011
- Necrobiotic xanthogranuloma: Isolated skeletal muscle involvement and unusual changesJournal of the American Academy of Dermatology, 2005
- Recombinant interferon alfa-2b treatment of necrobiotic xanthogranuloma with paraproteinemiaJournal of the American Academy of Dermatology, 1995
- Necrobiotic xanthogranuloma without periorbital lesionsJournal of the American Academy of Dermatology, 1993
- Necrobiotic xanthogranuloma in a human T-lymphotropic virus type 1 carrierJournal of the American Academy of Dermatology, 1992
- Periorbital necrobiotic xanthogranuloma and stage I multiple myelomaJournal of the American Academy of Dermatology, 1991
- Complement consumption in a patient with necrobiotic xanthogranuloma and paraproteinemiaJournal of the American Academy of Dermatology, 1991